🚦Updates to colour grades: glecaprevir/pibrentasvir and elbasvir/grazoprevir both downgraded from 🟧AMBER to 🟨YELLOW due to weak inhibition of CYP3A4
March 10, 2025 at 3:05 PM
🚦Updates to colour grades: glecaprevir/pibrentasvir and elbasvir/grazoprevir both downgraded from 🟧AMBER to 🟨YELLOW due to weak inhibition of CYP3A4
Data for #MRK 1 pill duo of PI #Grazoprevir and NS5A inh #Elbasvir in cirrhotics/nulls/ HIV-HCV/renal dz @ #Liver14
http://bit.ly/1Eumq0G
http://bit.ly/1Eumq0G
Media - Merck.com
Merck's online newsroom offers real-time news about Merck...
bit.ly
December 3, 2024 at 2:27 PM
Data for #MRK 1 pill duo of PI #Grazoprevir and NS5A inh #Elbasvir in cirrhotics/nulls/ HIV-HCV/renal dz @ #Liver14
http://bit.ly/1Eumq0G
http://bit.ly/1Eumq0G
#MRK to present "ultra-short" C-SWIFT ph 2 data looking at 4 wk rx with #Grazoprevir/#Elbasvir+#Sovaldi @ #Liver14
http://bit.ly/1Eumq0G
http://bit.ly/1Eumq0G
Media - Merck.com
Merck's online newsroom offers real-time news about Merck...
bit.ly
December 3, 2024 at 2:27 PM
#MRK to present "ultra-short" C-SWIFT ph 2 data looking at 4 wk rx with #Grazoprevir/#Elbasvir+#Sovaldi @ #Liver14
http://bit.ly/1Eumq0G
http://bit.ly/1Eumq0G
Dr. Lawitz "#grazoprevir+#elbasvir +/- RBV for 12-18 wks yields 95% SVR12 in GT1 null responder cirrhotics. RBV may not be needed?" #liver14
December 3, 2024 at 1:56 PM
Dr. Lawitz "#grazoprevir+#elbasvir +/- RBV for 12-18 wks yields 95% SVR12 in GT1 null responder cirrhotics. RBV may not be needed?" #liver14
Merck Seeks #FDA Approval of #HCV combo #grazoprevir and #elbasvir http://www.aidsmeds.com/articles/grazoprevir_elbasvir_FDA_1667_27301.shtml#.VXdMdUitWiQ.twitter
404 Error - AIDSmeds
www.aidsmeds.com
December 3, 2024 at 1:31 PM
Merck Seeks #FDA Approval of #HCV combo #grazoprevir and #elbasvir http://www.aidsmeds.com/articles/grazoprevir_elbasvir_FDA_1667_27301.shtml#.VXdMdUitWiQ.twitter
PDUFA date for $MRK single tablet #grazoprevir & #elbasvir is 1/28/2016. Data for #HCV GT 1,4,6, #HIV & chronic kidney disease incl dialysis
December 3, 2024 at 1:15 PM
PDUFA date for $MRK single tablet #grazoprevir & #elbasvir is 1/28/2016. Data for #HCV GT 1,4,6, #HIV & chronic kidney disease incl dialysis
Merck Announces FDA Acceptance of Grazoprevir/Elbasvir NDA in certain HCV Genotypes http://sco.lt/6g31rV
VIGIE Pharma : Vie des laboratoires
VIGIE Pharma : Vie des laboratoires
sco.lt
December 3, 2024 at 1:15 PM
Merck Announces FDA Acceptance of Grazoprevir/Elbasvir NDA in certain HCV Genotypes http://sco.lt/6g31rV
#Merck C-SURFER study of #HCV combo #Elbasvir & #Grazoprevir in advanced Kidney Disease now in The Lancet http://www.mercknewsroom.com/news-release/hepatitis-c-newsroom/results-mercks-phase-3-study-investigational-chronic-hepatitis-c-t
Media - Merck.com
Merck's online newsroom offers real-time news about Merck...
www.mercknewsroom.com
December 3, 2024 at 12:55 PM
#Merck C-SURFER study of #HCV combo #Elbasvir & #Grazoprevir in advanced Kidney Disease now in The Lancet http://www.mercknewsroom.com/news-release/hepatitis-c-newsroom/results-mercks-phase-3-study-investigational-chronic-hepatitis-c-t
Dr. Terrault: #grazoprevir #elbasvir combo without RBV gives high #HCV cure in advanced kidney disease incl. dialysis #LiverLeader #Liver15
December 3, 2024 at 12:29 PM
Dr. Terrault: #grazoprevir #elbasvir combo without RBV gives high #HCV cure in advanced kidney disease incl. dialysis #LiverLeader #Liver15
C-Edge co-star study of #grazoprevir #elbasvir in #HCV pts on opioid agonists: high adherence & 95% SVR12 in GT1,4-6 #Liver15 #LiverLeader
December 3, 2024 at 12:09 PM
C-Edge co-star study of #grazoprevir #elbasvir in #HCV pts on opioid agonists: high adherence & 95% SVR12 in GT1,4-6 #Liver15 #LiverLeader
Dr. Jacobson: 12 wk #grazoprevir #elbasvir in cirrhotics for #HCV GT1,4,5,6 incl. coinfection & CKD cures 98% naives #Liver15 #LiverLeader
December 3, 2024 at 11:59 AM
Dr. Jacobson: 12 wk #grazoprevir #elbasvir in cirrhotics for #HCV GT1,4,5,6 incl. coinfection & CKD cures 98% naives #Liver15 #LiverLeader
Dr. Sperl: #grazoprevir & #elbasvir is better than #sofosbuvir #peginterferon #ribavirin in GT1 and 4 patients given 12 weeks. #ILC2016
December 3, 2024 at 10:32 AM
Dr. Sperl: #grazoprevir & #elbasvir is better than #sofosbuvir #peginterferon #ribavirin in GT1 and 4 patients given 12 weeks. #ILC2016
@AASLDtweets grazoprevir/elbasvir/sofosbuvir cures 96% TN & 94% TE cirrhotic GT3 #HCV. 100% completers cured #LiverMtg16
December 3, 2024 at 8:31 AM
@AASLDtweets grazoprevir/elbasvir/sofosbuvir cures 96% TN & 94% TE cirrhotic GT3 #HCV. 100% completers cured #LiverMtg16
@AASLDtweets dr chalasani cites paritaprevir, grazoprevir and obethiclolic acid as associated with DILI in some pts with advanced liver disease due to increased exposure. I would argue that in most of these cases, this is true/true and unrelated #livermtg18
December 3, 2024 at 5:02 AM
@AASLDtweets dr chalasani cites paritaprevir, grazoprevir and obethiclolic acid as associated with DILI in some pts with advanced liver disease due to increased exposure. I would argue that in most of these cases, this is true/true and unrelated #livermtg18
Retweeted CTAC (@CTAC_CAN):
New HCV medication Elbasvir/Grazoprevir receives its Notice of Compliance from... http://fb.me/7Mac03Yjw
New HCV medication Elbasvir/Grazoprevir receives its Notice of Compliance from... http://fb.me/7Mac03Yjw
Войдите на Facebook
Войдите на Facebook, чтобы общаться с друзьями, родственн...
fb.me
February 20, 2025 at 8:55 AM
Retweeted CTAC (@CTAC_CAN):
New HCV medication Elbasvir/Grazoprevir receives its Notice of Compliance from... http://fb.me/7Mac03Yjw
New HCV medication Elbasvir/Grazoprevir receives its Notice of Compliance from... http://fb.me/7Mac03Yjw
Retweeted CTAC (@CTAC_CAN):
New HCV medication Elbasvir/Grazoprevir receives its Notice of Compliance from... http://fb.me/7Mac03Yjw
New HCV medication Elbasvir/Grazoprevir receives its Notice of Compliance from... http://fb.me/7Mac03Yjw
Войдите на Facebook
Войдите на Facebook, чтобы общаться с друзьями, родственн...
fb.me
February 19, 2025 at 11:40 PM
Retweeted CTAC (@CTAC_CAN):
New HCV medication Elbasvir/Grazoprevir receives its Notice of Compliance from... http://fb.me/7Mac03Yjw
New HCV medication Elbasvir/Grazoprevir receives its Notice of Compliance from... http://fb.me/7Mac03Yjw